AcouSort AB (publ) (ACOU.ST)
Stockholm · SEK · Healthcare · Biotechnology
SEK 3.26 (-1.51%) as of
Key statistics
- Market cap
- 68.99M
- Forward P/E
- -4.07
- EPS (TTM)
- -0.5200
- Dividend yield
- 0.00%
- 52-week range
- 2.0300 – 5.1600
- Beta
- 0.13
- Revenue (TTM)
- 9.31M
- Profit margin
- -120.48%
- Analyst target
- SEK 9.00
- Volume
- 27.44k
About AcouSort AB (publ)
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Lund, Sweden
- Employees
- 11
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.